In patients with COVID-19, however, new-onset DM and severe metabolic consequences of current diabetes, such as diabetic ketoacidosis (DKA) and hyperosmolarity, necessitating extremely high insulin doses, have been reported. Here, INS is linked to diabetes mellitus.